Adagio Medical Holdings (ADGM) Net Cash Flow (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Net Cash Flow data on file, last reported at -$4.1 million in Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$4.1 million, up 45.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.7 million (up 51.35% YoY), and the FY2025 annual result was -$3.3 million, up 77.94% from the prior year.
• Net Cash Flow fell to -$4.1 million in Q1 2026 per ADGM's latest filing, from -$3.6 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $2.7 million in Q1 2024 and troughed at -$7.5 million in Q1 2025.
• A 4-year average of -$3.1 million and a median of -$3.6 million in 2025 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2025 and 2026: Net Cash Flow sank 378.15% in 2025, then surged 45.56% in 2026.
• A 4-year view of Net Cash Flow shows it stood at -$533000.0 in 2023, then sank by 1209.19% to -$7.0 million in 2024, then soared by 47.74% to -$3.6 million in 2025, then declined by 12.48% to -$4.1 million in 2026.
• Business Quant data shows ADGM's Net Cash Flow at -$4.1 million in Q1 2026, -$3.6 million in Q4 2025, and -$7.5 million in Q1 2025.